$Calliditas Therapeutics (CALT.US)$
NEWS
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Consistent improvement in estimated glomerular filtrate rate (eGFR) with Nefecon treatment compared to placebo.
30% reduction in UPCR with Nefecon sustained over 2 years, leading to lower risk of kidney failure.
Significantly delayed time to kidney function decline events with Nefecon c...

$Alphabet-A (GOOGL.US)$
Google admits that a Gemini AI demo video was staged
Do you think the market has internalised the implications of this news? Will this cause a major dip? Why did google have to “fake” its demo?
i hope it does.